In vitro evaluation of genotoxicity of a commercial polyaxial pedicle screw for spine surgery
Keywords:
Ames, Bacterial reverse mutation , Genotoxicity, in vitro micronucleusAbstract
Biocompatibility, which shows the compatibility between the host and the biomaterial, is very important for the reliability of a biomaterial. It is a must for a newly produced biomaterial to meet the biocompatibility criteria, which are bound to certain rules by international organizations. One of the criteria of biocompatibility is genotoxicity. In this study, it was aimed to evaluate the genotoxicity of a commercial polyaxial pedicle screw in vitro. For this purpose, in vitro micronucleus test and bacterial reverse mutation test were performed. Extraction method was used for both tests. When the obtained results were compared statistically, it was concluded that the tested biomaterial was not genotoxic.
References
Breheny C, Blacklock KB, Gunn‐Moore D. 2022a. Approach to urethral obstruction in cats. Part 1: presentation and stabilisation. In practice, 44 (7):372-384.
Breheny C, Blacklock KB, Gunn‐Moore D. 2022b. Approach to urethral obstruction in cats. Part 2: catheterising and postobstruction management. In practice, 44(8):452-464.
Cooper ES, Lasley E, Daniels JB, Chew DJ. 2019. Incidence of bacteriuria at presentation and resulting from urinary catheterization in feline urethral obstruction. Journal of veterinary emergency and critical care, 29(5):472-477.
Dasgupta J, Tincello DG. 2009. Interstitial cystitis/bladder pain syndrome: an update. Maturitas, 64(4):212-217.
Delcaru C, Alexandru I, Podgoreanu P et al. 2016. Microbial biofilms in urinary tract infections and prostatitis: Etiology, pathogenicity, and combating strategies. Pathogens, 5(4):65.
Eisenberg BW, Waldrop JE, Allen SE et al. 2013. Evaluation of risk factors associated with recurrent obstruction in cats treated medically for urethral obstruction. Journal of the American Veterinary Medical Association, 243(8):1140-1146.
Fall M, Oberpenning F, Peeker R. 2008. Treatment of bladder pain syndrome/interstitial cystitis 2008: can we make evidence-based decisions? European Urology, 54(1):65-78.
Ferreira GS. 2013. Características epidemiológicas, clínicas e laboratoriais de gatos com sinais de trato urinário inferior. Journal of the American Veterinary Medical Association, 243(8):1140-1146.
Gerber B, Eichenberger S, Reusch CE et al. 2008. Guarded long-term prognosis in male cats with urethral obstruction. Journal of Feline Medicine and Surgery, 10(1):16-23.
Grønseth T, Ovchinnikov KV, Carlsen H. 2023. Lugol's solution and Gentian violet eradicate methicillin‐resistant Staphylococcus aureus biofilm in skin wound infections. International Wound Journal, 20(1):120-130.
Hanno P, Lin A, Nordling J et al. 2010. Bladder pain syndrome international consultation on incontinence. Neurourology and Urodynamics: Official Journal of the International Continence Society, 29(1):191-198.
Hetrick PF, Davidow EB. 2013. Initial treatment factors associated with feline urethral obstruction recurrence rate: 192 cases (2004-2010). Journal of the American Veterinary Medical Association, 243(4):512-519.
Kim R, Liu W, Chen X, Kreder KJ, Luo Y. 2011. Intravesical dimethyl sulfoxide inhibits acute and chronic bladder inflammation in transgenic experimental autoimmune cystitis models. BioMed Research International, 2011:937061.
Lee JA, Drobatz KJ. 2006. Historical and physical parameters as predictors of severe hyperkalemia in male cats with urethral obstruction. Journal of Veterinary Emergency and Critical Care, 16(2):104-111.
Lulich J, Osborne C. 2013. Prazosin in cats with urethral ob Albanese K, Ordway NR, Albanese SA, Lavelle WF. 2017. Effect of pedicle fill on axial pullout strength in spinal fixation after rod reduction. Orthopedics, 40(6):e990-e995.
Assad M, Jackson N. 2019. Biocompatibility evaluation of orthopedic biomaterials and medical devices: A review of safety and efficacy models. Encyclopedia of Biomedical Engineering, 281-309.
Elshahawy W. 2011. Biocompatibility. In Advances in Ceramics-Electric and Magnetic Ceramics, Bioceramics, Ceramics and Environment. IntechOpen.
George M, Naveen SV, Murali MR, Murugan SS, Kumaravel TS, Sathya TN. 2023. Review of selected orthopaedic implants for their genotoxicity potential. Indian Journal of Science and Technology, 16(30):2311-2316.
Gotman I. 1997. Characteristics of metals used in implants. Journal of Endourology, 11(6):383-389.
Huzum B, Puha B, Necoara RM, Gheorghevici S, Puha G, Filip A, Sirbu PD, Alexa O. 2021. Biocompatibility assessment of biomaterials used in orthopedic devices: An overview. Experimental and Therapeutic Medicine, 22(5): 1-9.
ISO 10993-1. 2018. Biological evaluation of medical devices. Part 1: Evaluation and testing within a risk management process. Geneva, Switzerland: International Standard Organization.
ISO 10993-3. 2018. Biological evaluation of medical devices. Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity. Geneva, Switzerland: International Standard Organization.
Kwon J, Ha MH, Lee MG. 2020. Alternative pedicle screw design via biomechanical evaluation. Applied Sciences, 10(14):4746.
Latka K, Kolodziej W, Domisiewicz K, Lasowy P, Latka D. 2024. Medical implant heavy metal contents and effect on patients. Biomedical and Biotechnology Research Journal, 8(3):267-273.
Merk O, Speit G. 1999. Detection of crosslinks with the comet assay in relationship to genotoxicity and cytotoxicity. Environmental and Molecular Mutagenesis, 33(2):167-172.
Mohamed SAKS, Sabita U, Rajendra S, Raman D. 2017. Genotoxicity: mechanisms, testing guidelines and methods. Global Journal of Pharmacy Pharmaceutical Sciences, 1(5):1-6.
Ribeiro DA, Matsumoto MA, Padovan LEM, Marques MEA, Salvadori DMF. 2007. Genotoxicity of corrosion eluates obtained from endosseous implants. Implant Dentistry, 16 (1), 101-109.
Schliephake H, Reiss G, Urban R, Neukam FW, Guckel S. 1993. Metal release from titanium fixtures during placement in the mandible: An experimental study. International Journal of Oral & Maxillofacial Implants, 8(5):502-511.
Williams DF. 2008. On the mechanisms of biocompatibility. Biomaterials, 29 (20), 2941-2953.struction. Journal of the American Veterinary Medical Association, 243(9):1240-1240.
Osborne CA, Kruger JM, Lulich JP, Bartges JW, Polzin DJ. 1996. Medical management of feline urethral obstruction. Veterinary Clinics Small Animal Practice, 26 (3):483-498.
Reineke EL, Thomas EK, Syring RS, Savini J, Drobatz KJ. 2017. The effect of prazosin on outcome in feline urethral obstruction. Journal of Veterinary Emergency and Critical Care, 27(4):387-396.
Segev G, Livne H, Ranen E, Lavy E. 2011. Urethral obstruction in cats: predisposing factors, clinical, clinicopathological characteristics and prognosis. Journal of Feline Medicine and Surgery, 13(2):101-108.
Soler R, Bruschini H, Truzzi JC et al. 2008. Urinary glycosaminoglycans excretion and the effect of dimethyl sulfoxide in an experimental model of non-bacterial cystitis. Internal Brazial Journal Urol, 34:503-511.
Taranu T, Constantin MM, Toader MP, Esanu I, Mocanu M. 2018. The benefits of using the Iodine solution in the treatment of acne at pregnant women. Reviev Chimestry, 69:2343-2345.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 International Journal of Veterinary and Animal Research (IJVAR)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
